nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment
|
Müller, Sebastian A. |
|
2009 |
36 |
9 |
p. 1434-1442 |
artikel |
2 |
Commentary on: Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients
|
Brenot-Rossi, Isabelle |
|
2009 |
36 |
9 |
p. 1375-1376 |
artikel |
3 |
Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer
|
Esser, S. van |
|
2009 |
36 |
9 |
p. 1383-1387 |
artikel |
4 |
Darwinian molecular imaging
|
Tavitian, Bertrand |
|
2009 |
36 |
9 |
p. 1475-1482 |
artikel |
5 |
EANM guidelines for ventilation/perfusion scintigraphy
|
Bajc, M. |
|
2009 |
36 |
9 |
p. 1528-1538 |
artikel |
6 |
Eugene C. Lin, Edward J. Escott, Kavita D. Garg, Andrew G. Bleicher, David Alexander: Practical differential diagnosis for CT and MRI
|
Sacco, Maurizio |
|
2009 |
36 |
9 |
p. 1526 |
artikel |
7 |
[18F]Fluoroacetate is not a functional analogue of [11C]acetate in normal physiology
|
Lindhe, Örjan |
|
2009 |
36 |
9 |
p. 1453-1459 |
artikel |
8 |
18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK)
|
Hultsch, Christina |
|
2009 |
36 |
9 |
p. 1469-1474 |
artikel |
9 |
Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging
|
Zissen, Maurice H. |
|
2009 |
36 |
9 |
p. 1527 |
artikel |
10 |
68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging
|
Liu, Zhaofei |
|
2009 |
36 |
9 |
p. 1483-1494 |
artikel |
11 |
Incidental head and neck 18F-FDG uptake on PET/CT without corresponding morphological lesion: early predictor of cancer development?
|
Heusner, Till A. |
|
2009 |
36 |
9 |
p. 1397-1406 |
artikel |
12 |
In vitro characterization of 177Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study
|
Forrer, Flavio |
|
2009 |
36 |
9 |
p. 1443-1452 |
artikel |
13 |
Monitoring cancer therapy with PET: probably effective, but more research is needed
|
Lucignani, Giovanni |
|
2009 |
36 |
9 |
p. 1520-1525 |
artikel |
14 |
Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with 64Cu-DOTA-trastuzumab
|
Niu, Gang |
|
2009 |
36 |
9 |
p. 1510-1519 |
artikel |
15 |
99Mo supply—the times they are a-changing
|
Lewis, Dewi M. |
|
2009 |
36 |
9 |
p. 1371-1374 |
artikel |
16 |
Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
|
Bartolomei, Mirco |
|
2009 |
36 |
9 |
p. 1407-1416 |
artikel |
17 |
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT
|
Kitajima, Kazuhiro |
|
2009 |
36 |
9 |
p. 1388-1396 |
artikel |
18 |
188Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study
|
Lam, Marnix G. E. H. |
|
2009 |
36 |
9 |
p. 1425-1433 |
artikel |
19 |
Staging primary head and neck cancers with 18F-FDG PET/CT: is intravenous contrast administration really necessary?
|
Yoshida, Keisuke |
|
2009 |
36 |
9 |
p. 1417-1424 |
artikel |
20 |
Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with 99mTc- and 123I-labelled probes
|
Pissarek, M. |
|
2009 |
36 |
9 |
p. 1495-1509 |
artikel |
21 |
The influence of Bz-DOTA and CHX-A″-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for 114mIn-mediated targeting therapy
|
Tolmachev, Vladimir |
|
2009 |
36 |
9 |
p. 1460-1468 |
artikel |
22 |
Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients
|
Holl, G. |
|
2009 |
36 |
9 |
p. 1377-1382 |
artikel |